Results 51 to 60 of about 21,238,241 (185)
The International Journal of Biological Markers, 2019 From January 2018 to May 2018, 108 patients with thoracic esophageal cancer underwent esophagectomy with two- to three-field lymph node dissection.
Xinyu Mei +5 more
doaj +1 more source
Serum CYFRA21-1 as an effective tumor biomarker for patients with nasopharyngeal carcinoma
Neoplasma, 2015 We investigated if the serum cytokeratin 19 fragment 21.1 (CYFRA21-1) level was elevated in nasopharyngeal carcinoma (NPC) and can function as a biomarker for detection and monitoring of NPC. Three hundred and one study subjects were divided into two groups: the NPC group (n=126) and healthy control group (n=175).
X M, Song +5 more
openaire +3 more sources
Life, 2021 Radon is a major cause of lung cancer (LC) deaths among non-smokers worldwide. However, no serum biomarker for screening of LC risk in high residential radon (HRR) areas is available. Therefore, the aim of this study was to determine diagnostic values of
Narongchai Autsavapromporn +7 more
doaj +1 more source
CYFRA21-1 levels could be a biomarker for bladder cancer: a meta-analysis
Genetics and Molecular Research, 2015 The proteolytic region of cytokeratin-19, referred to as CYFRA21-1, is a soluble molecule present in the serum and other body fluids, and is considered a tumor marker in several neoplastic diseases. To examine whether urinary or serum samples containing CYFRA21-1 can be used as biomarkers for bladder cancer, we conducted a comprehensive meta-analysis ...
L I, Kuang +4 more
openaire +2 more sources
, 2016 Objectives: To investigate the role of cytokeratin-19 fragment (CYFRA21-1) in cervical lesions screening in high-risk human papillomavirus (HR-HPV) infected women. Material and methods: The study was a retrospective study.
Jia, Yang +2 more
core +1 more source
Mechanisms of the release of CYFRA21-1 in human lung cancer cell lines
Lung Cancer, 2000 The CYFRA 21-1 assay which detects cytokeratin 19 (CK19) fragment is widely used as a tumor marker for lung cancer. However, the reason why some lung cancer cell lines release CK19 fragment in culture supernatants and others do not, remains unclear. It was hypothesized that the release of CK19 fragment may be elucidated by the expression of mRNA for ...
K, Dohmoto +8 more
openaire +3 more sources
Cancer Medicine, Volume 15, Issue 6, June 2026.ABSTRACT Background Early diagnosis of colorectal cancer (CRC) can significantly improve prognosis, but currently there is a lack of simple and effective screening methods in clinical practice. Methods This single‐center retrospective study included patients with CRC and benign colorectal polyps (BCP) diagnosed at our hospital between December 2020 and
Xiaofan Liu +8 more
wiley +1 more source
International Journal of Cancer, Volume 158, Issue 9, Page 2418-2428, 1 May 2026.What's new? Cavity carcinomatosis, a late manifestation of cancer, fuels tumor formation throughout a large area, most commonly the peritoneal and pleural cavities. The condition also can lead to resistance to otherwise effective treatment strategies.
Zhongqiao Lin +6 more
wiley +1 more source
Diagnostic Cytopathology, Volume 54, Issue 4, Page E87-E92, April 2026.ABSTRACT Malignant mesothelioma (MM) is a rare yet aggressive neoplasm that arises from mesothelial cells lining the thoracic and abdominal cavities, the pericardium, and the tunica testis. Characterized by rapid progression, high invasiveness, and a poor prognosis, MM poses significant clinical challenges. SMARCB1, also referred to as INI‐1, hSNF5, or
Jun Yang +4 more
wiley +1 more source
Respirology Case Reports, Volume 14, Issue 4, April 2026.We report a case of gastric signet ring cell carcinoma with pulmonary lymphangitic carcinomatosis as the initial manifestation without gastrointestinal symptoms confirmed by CT‐guided percutaneous lung biopsy, with the aim of providing insights into diagnostic methods and differential diagnosis of similar cases.
Ping Li +3 more
wiley +1 more source